Immuron Limited (ASX:IMC)
Australia · Delayed Price · Currency is AUD 0.0450
0.00 (0.00%)
Oct 7, 2026, 2:01 PM AEST
Immuron Market Cap
Immuron has a market cap or net worth of 14.53 million as of October 9, 2026. It is the 41,593rd most valuable company in the world and the 1,222nd biggest in Australia. Its market cap has decreased by 39.14% in one year.
Market Cap
14.53M
Enterprise Value
5.70M
Revenue
7.71M
Global Rank
Country Rank
#1,222 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since September 14, 1999, Immuron's market cap has decreased from 37.31M to 14.53M, a decrease of -61.06%. That is a compound annual growth rate of -3.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 14.53M | 23.98% |
| Dec 31, 2025 | 11.72M | -35.27% |
| Dec 30, 2024 | 18.10M | 3.20% |
| Dec 29, 2023 | 17.54M | -10.47% |
| Dec 30, 2022 | 19.59M | -14.00% |
| Dec 31, 2021 | 22.78M | -56.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Imugene | 20.08M |
| Proteomics International Laboratories | 19.84M |
| Ceryvyn Therapeutics | 19.15M |
| Noxopharm | 19.05M |
| Algorae Pharmaceuticals | 18.25M |
| Patrys | 18.05M |
| Argenica Therapeutics | 16.70M |
| EZZ Life Science Holdings | 16.47M |